Cost-effectiveness of an urinary biomarker panel in combination with MRI for prostate cancer diagnosis

Tim M. Govers, Matthew J Resnick, Ardeshir R. Rastinehad, Laura Caba, Jack Groskopf, Wim van Criekinge

Open source

DOI
10.1007/s00345-023-04389-w
Published
2023-05-03
Container
World Journal of Urology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00345-023-04389-w,
  title = {Cost-effectiveness of an urinary biomarker panel in combination with MRI for prostate cancer diagnosis},
  author = {Tim M. Govers and Matthew J Resnick and Ardeshir R. Rastinehad and Laura Caba and Jack Groskopf and Wim van Criekinge},
  year = {2023},
  journal = {World Journal of Urology},
  doi = {10.1007/s00345-023-04389-w},
  url = {https://doi.org/10.1007/s00345-023-04389-w}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness of an urinary biomarker panel in combination with MRI for prostate cancer diagnosis
AU  - Tim M. Govers
AU  - Matthew J Resnick
AU  - Ardeshir R. Rastinehad
AU  - Laura Caba
AU  - Jack Groskopf
AU  - Wim van Criekinge
PY  - 2023
JO  - World Journal of Urology
DO  - 10.1007/s00345-023-04389-w
UR  - https://doi.org/10.1007/s00345-023-04389-w
ER  - 

APA

Govers, T. M., Resnick, M. J., Rastinehad, A. R., Caba, L., Groskopf, J., & Criekinge, W. V. (2023). Cost-effectiveness of an urinary biomarker panel in combination with MRI for prostate cancer diagnosis. World Journal of Urology. https://doi.org/10.1007/s00345-023-04389-w

Source records